James (Josh) Wilson Faruqi & Faruqi, LLP
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MongoDB
August 02, 2024 10:05 ET | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In MongoDB To Contact Him Directly To Discuss Their Options ...
James (Josh) Wilson Faruqi & Faruqi, LLP
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of 2U
August 02, 2024 09:55 ET | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In 2U To Contact Him Directly To Discuss Their Options If you...
logo-horizontal-main.png
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
August 01, 2024 16:05 ET | OncoCyte Corporation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Five Below
August 01, 2024 15:36 ET | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Five Below To Contact Him Directly To Discuss Their Options ...
Strong Clinical Momentum for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian Poligone
August 01, 2024 09:00 ET | PRISM Mediawire
Strong Clinical Momentum for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian Poligone
Captura de pantalla 2023-11-10 082355 big.png
Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
August 01, 2024 08:00 ET | Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
Logo 1200x628.jpg
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
August 01, 2024 07:00 ET | CytoSorbents
CytoSorbents regains compliance with Nasdaq minimum bid price requirement
VSAC Logo.png
Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to September 3, 2024
July 31, 2024 16:35 ET | Vision Sensing Acquisition Corp.
Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to September 3, 2024
BlackLogo_Flat.png
Intuitive Machines Announces Date for Second Quarter 2024 Financial Results Conference Call
July 31, 2024 16:24 ET | Intuitive Machines, LLC
HOUSTON, July 31, 2024 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) (“Intuitive Machines”) (“Company”) announced today that it will release its financial results for the second...
pineapple-energy-logo.jpg
Pineapple Energy Regains Compliance With Nasdaq Equity Listing Rule
July 31, 2024 16:05 ET | Pineapple Energy
Pineapple’s newly regained compliance relates to Listing Rule 5550(b)(1), also known commonly as the “Equity Rule.”